We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
-2.98%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$251M
AUM Growth
-$19M
Cap. Flow
-$2.24M
Cap. Flow %
-0.89%
Top 10 Hldgs %
7.1%
Holding
477
New
43
Increased
256
Reduced
137
Closed
41

Top Buys

Rank Stock Value
1
MOS icon
The Mosaic Company
MOS
+$962K
2
EMB icon
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
+$944K
3
ENPH icon
Enphase Energy
ENPH
+$834K
4
DVN icon
Devon Energy
DVN
+$751K
5
IT icon
Gartner
IT
+$742K

Top Sells

Rank Stock Value
1
MRNA icon
Moderna
MRNA
+$785K
2
LHX icon
L3Harris
LHX
+$740K
3
A icon
Agilent Technologies
A
+$713K
4
CPRT icon
Copart
CPRT
+$688K
5
CQP icon
Cheniere Energy
CQP
+$687K

Sector Composition

Rank Sector Weight
1 Healthcare 18.83%
2 Real Estate 17.55%
3 Materials 12.77%
4 Financials 9.88%
5 Energy 9.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PHAT icon
326
Phathom Pharmaceuticals
PHAT
$931M
$187K 0.07%
16,847
+121
+0.7% +$1.15K
BCYC
327
Bicycle Therapeutics
BCYC
$272M
$186K 0.07%
8,009
+63
+0.8% +$1.5K
OFS icon
328
OFS Capital
OFS
$46.1M
$183K 0.07%
22,215
-2,527
-10% -$26.2K
PGEN icon
329
Precigen
PGEN
$1.95B
$182K 0.07%
85,618
+618
+0.7% +$1.3K
RXRX icon
330
Recursion Pharmaceuticals
RXRX
$1.59B
$179K 0.07%
16,847
+121
+0.7% +$1.23K
FLNA
331
Filana Therapeutics
FLNA
$42.3M
$178K 0.07%
4,267
+26
+0.6% +$702
IBRX icon
332
ImmunityBio
IBRX
$7.21B
$174K 0.07%
35,048
+249
+0.7% +$1.14K
EWTX icon
333
Edgewise Therapeutics
EWTX
$4.31B
$172K 0.07%
17,469
+128
+0.7% +$1.29K
CCCC icon
334
C4 Therapeutics
CCCC
$389M
$169K 0.07%
19,305
+136
+0.7% +$1.41K
IMVT icon
335
Immunovant
IMVT
$7.83B
$169K 0.07%
30,367
+221
+0.7% +$1.08K
LYEL icon
336
Lyell Immunopharma
LYEL
$321M
$169K 0.07%
1,156
+9
+0.8% +$1.22K
RAPT
337
DELISTED
RAPT Therapeutics
RAPT
$169K 0.07%
877
+6
+0.7% +$1.14K
ERAS icon
338
Erasca
ERAS
$6.01B
$168K 0.07%
21,487
+150
+0.7% +$1.21K
RLAY icon
339
Relay Therapeutics
RLAY
$3.96B
$168K 0.07%
7,526
+50
+0.7% +$1.1K
IGMS
340
DELISTED
IGM Biosciences
IGMS
$166K 0.07%
7,319
+52
+0.7% +$1.05K
AMRS
341
DELISTED
Amyris Inc.
AMRS
$166K 0.07%
56,770
+411
+0.7% +$1.12K
AGEN
342
Agenus
AGEN
$274M
$165K 0.07%
4,094
+30
+0.7% +$1.53K
TGTX icon
343
TG Therapeutics
TGTX
$8.25B
$161K 0.06%
27,135
+200
+0.7% +$1.31K
PRLD icon
344
Prelude Therapeutics
PRLD
$362M
$160K 0.06%
24,180
+175
+0.7% +$1.18K
SNDX icon
345
Syndax Pharmaceuticals
SNDX
$1.69B
$159K 0.06%
6,628
+44
+0.7% +$987
KYMR icon
346
Kymera Therapeutics
KYMR
$8.61B
$157K 0.06%
7,222
+51
+0.7% +$1.34K
RCKT icon
347
Rocket Pharmaceuticals
RCKT
$337M
$157K 0.06%
9,860
+68
+0.7% +$1.06K
SGMO
348
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$155K 0.06%
31,651
+227
+0.7% +$1.17K
IMGN
349
DELISTED
Immunogen Inc
IMGN
$155K 0.06%
32,341
+235
+0.7% +$1.24K
DICE
350
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
$153K 0.06%
7,540
+58
+0.8% +$1.06K
12 13
14
15 16

Similar funds

NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
GC
GatePass Capital Independence, Ohio $214M AUM 29.83% 1-Year Est. Return
RC
Roubaix Capital Denver, Colorado $214M AUM 32.43% 1-Year Est. Return

Virtus ETF Advisers's Q3 2022 Portfolio in Review

As of Q3 2022, Virtus ETF Advisers held 477 positions worth $251M, down 7% from $270M the previous quarter. Its ten largest holdings account for 7.1% of the portfolio.

Virtus ETF Advisers's Q3 2022 filing shows 43 new, 256 increased, 137 reduced and 41 closed positions. Its largest new stake was iShares JPMorgan USD Emerging Markets Bond ETF: 11,040 shares worth $877K. The largest sale was Moderna, an estimated $785K.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 17% a quarter earlier, followed by Real Estate and Materials.

  • Virtus ETF Advisers's largest Q3 2022 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 11,040 shares worth $877K.
  • Virtus ETF Advisers added most to The Mosaic Company in Q3 2022, an estimated $962K increase.
  • Virtus ETF Advisers's biggest Q3 2022 reduction was Moderna, cutting an estimated $785K.
  • Virtus ETF Advisers fully exited L3Harris in Q3 2022, selling an estimated $740K.
  • Virtus ETF Advisers's ten largest holdings make up 7.1% of its $251M portfolio in Q3 2022.
  • Virtus ETF Advisers opened 43 new positions and closed 41 in Q3 2022.
  • Virtus ETF Advisers's portfolio value fell 7% quarter-over-quarter to $251M.

Based on Virtus ETF Advisers's 13F filing for Q3 2022, filed 14 Nov 2022.